- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 13-11-2025: Press Release
13-11-2025 | 08:08 pm
13-11-2025 | 08:08 pm
Marksans Pharma reported record Q2 revenue of ₹720.4 Cr. EBITDA surged 44% QoQ, and PAT grew 70% QoQ, driven by robust US market demand and new product launches. The UK business remained stable, with new filings supporting future growth. Cash balance stands at ₹666.5 Cr.
No comments yet. Be the first to comment!